Start | Grid View | Browse by Day OR Group/Topical | Author Index | Keyword Index | Personal Scheduler

Implementation of QbD In the Development of a CR Dosage Form

Wednesday, October 19, 2011: 4:55 PM
Symphony III (Hilton Minneapolis)
Nancy E. Sever, Global Formulation Sciences, Abbott Laboratories, Abbott Park, IL, Michael Brian Mackaplow, Global Formulation Sciences- Solids, Abbott, Abbott Park, IL and Didier LeFebvre, Abbott, Abbott Park, IL

Use of QbD in characterization and development of a modified release dosage form will be discussed.  Special emphasis will be placed on the early stages of development and the utilization of material sparing, strategic experimental design to ascertain the critical parameters affecting the performance of the dosage unit.  Lab to Pilot to Commercial scale transfer will be discussed in terms of a QbD based approach.  In addition to formulation development, opportunities for QbD in analytical method development will also be presented.

Additional information will be provided upon legal approval - End of May.


Extended Abstract: File Not Uploaded
See more of this Session: QbD for Modified Release Dosage Forms
See more of this Group/Topical: Topical I: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture